# Pharmacokinetics of Inhaled Monodisperse Fluticasone Propionate

> **NCT00692978** · PHASE4 · COMPLETED · sponsor: **Imperial College London** · enrollment: 30 (actual)

## Conditions studied

- Healthy
- Asthma

## Interventions

- **DRUG:** Fluticasone Propionate_1.5
- **DRUG:** Fluticasone Propionate_3
- **DRUG:** Fluticasone Propionate_6
- **DRUG:** FP From Active 250 ug MDI Inhaler

## Key facts

- **NCT ID:** NCT00692978
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-07-03
- **Final completion:** 2011-07-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692978, "Pharmacokinetics of Inhaled Monodisperse Fluticasone Propionate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00692978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*